Prospective phase II study of frontline Helicobacter pylori eradication therapy for early-stage extragastric mucosa-associated lymphoid tissue lymphoma - Poll - MDSpire

Prospective phase II study of frontline Helicobacter pylori eradication therapy for early-stage extragastric mucosa-associated lymphoid tissue lymphoma

  • By

  • Ming Yao

  • Xavier Cheng-Hong Tsai

  • Chung-Wu Lin

  • Shu-Lang Liao

  • Cheng-Ping Wang

  • Wei-Li Ma

  • Yi-Hsuan Wei

  • Hsiao-Wei Lee

  • Jyh-Ming Liou

  • Wei-Li Chen

  • I-Jong Wang

  • Ann-Lii Cheng

  • Sung-Hsin Kuo

  • May 29, 2026

  • 0 min

Share

Original Source(s)

Prospective phase II study of frontline Helicobacter pylori eradication therapy for early-stage extragastric mucosa-associated lymphoid tissue lymphoma

  • by Ming Yao, Xavier Cheng-Hong Tsai, Chung-Wu Lin, Shu-Lang Liao, Cheng-Ping Wang, Wei-Li Ma, Yi-Hsuan Wei, Hsiao-Wei Lee, Jyh-Ming Liou, Wei-Li Chen, I-Jong Wang, Ann-Lii Cheng, Sung-Hsin Kuo

  • May 29, 2026

Related Content

Impact of the clonal architecture and probable biallelic inactivation of TET2 mutations in myelodysplastic neoplasms

Emerging applications of artificial intelligence for risk stratification in head and neck cancer: a scoping review

Percutaneous nephrostomy as a marker of clinical vulnerability in non-metastatic muscle-invasive bladder cancer: prognostic and infectious implications